0000939767-17-000117.txt : 20170526
0000939767-17-000117.hdr.sgml : 20170526
20170526205336
ACCESSION NUMBER: 0000939767-17-000117
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170525
FILED AS OF DATE: 20170526
DATE AS OF CHANGE: 20170526
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EXELIXIS, INC.
CENTRAL INDEX KEY: 0000939767
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 043257395
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0102
BUSINESS ADDRESS:
STREET 1: 210 E. GRAND AVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 6508377000
MAIL ADDRESS:
STREET 1: 210 E. GRAND AVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: EXELIXIS INC
DATE OF NAME CHANGE: 20000207
FORMER COMPANY:
FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20000106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smith Julie
CENTRAL INDEX KEY: 0001557928
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30235
FILM NUMBER: 17875390
MAIL ADDRESS:
STREET 1: C/O RAPTOR PHARMACEUTICAL CORP
STREET 2: 9 COMMERCIAL BLVD, SUITE 200
CITY: NOVATO
STATE: CA
ZIP: 94949
4
1
wf-form4_149584640178321.xml
FORM 4
X0306
4
2017-05-25
0
0000939767
EXELIXIS, INC.
EXEL
0001557928
Smith Julie
C/O EXELIXIS, INC.
210 EAST GRAND AVE.
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Option (right to buy)
19.57
2017-05-25
4
A
0
23491
0
A
2017-05-25
2024-05-24
Common Stock
23491.0
23491
D
Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 1/12th of the shares subject to the option each month following the date of grant, subject to the Reporting Person's continuous service through such dates.
Jeffrey J. Hessekiel, Attorney in Fact
2017-05-26